Advanced search
Publication Cover
Future Science OA Volume 7, 2021 - Issue 2
Submit an article Journal homepage
9,542
Views
7
CrossRef citations to date
0
Altmetric
Commentary

Announcing the Novel Class of GABA–A Receptor Selective Positive Allosteric Modulator Antidepressants

Olumuyiwa John Fasipe1 Department of Clinical Pharmacology & Therapeutics, Faculty of Basic Clinical Sciences, University of Medical SciencesOndo CityOndo StateNigeriaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8761-1709
ORCID Icon,
Olalekan Ayodele Agede2 Department of Clinical Pharmacology & Therapeutics, Faculty of Basic Clinical Sciences, University of IlorinIlorinKwara StateNigeria
&
Adenike Christiana Enikuomehin3 Department of Internal Medicine, Faculty of Clinical Sciences, University of Medical SciencesOndo CityOndo StateNigeria
Article: FSO654 | Received 22 Jun 2020, Accepted 21 Oct 2020, Published online: 12 Nov 2020

References

  • FasipeOJ. Neuropharmacological classification of antidepressant agents based on their mechanisms of action. Arch. Med. Health Sci.6(1), 81–94 (2018).
  • FasipeOJ. Moving from the old monoaminergic theory toward the emerging hypothesis in the rational design of rapid-onset novel antidepressants. Med. J. DY Patil Vidyapeeth12(4), 292–315 (2019).
  • FasipeOJ. The emergence of new antidepressants for clinical use: agomelatine paradox versus other novel agents. IBRO Rep.6(1), 95–110 (2019).
  • FasipeOJ , AkhidenoPE , OwhinOS , Ibiyemi-FasipeOB. Announcing the first novel class of rapid-onset antidepressants in clinical practice. J. Med. Sci.39(5), 205–216 (2019).
  • WilkinsonST , SanacoraG. “A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems“. Drug Discov. Today24(2), 606–615 (2019).
  • ZorumskiCF , PaulSM , CoveyDF , MennerickS. “Neurosteroids as novel antidepressants and anxiolytics: GABA–A receptors and beyond“. Neurobiol. Stress11, 100196 (2019).
  • ReddyDS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog. Brain Res.186, 113–137 (2010).
  • MartinezBotella G , SalituroFG , HarrisonBLet al.“Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): a clinical next generation neuroactive steroid positive allosteric modulator of the gamma-aminobutyric acid−A receptor“. J. Med. Chem.60(18), 7810–7819 (2017).
  • FriederA , FershM , HainlineR , DeligiannidisKM. “Pharmacotherapy of postpartum depression: current approaches and novel drug development“. CNS Drugs33(3), 265–282 (2019).
  • KaminskiRM , LivingoodMR , RogawskiMA. “Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice“. Epilepsia45(7), 864–867 (2004).
  • PinnaG , UzunovaV , MatsumotoKet al.“Brain allopregnanolone regulates the potency of the GABA–A receptor agonist muscimol“. Neuropharmacology39(3), 440–448 (2000).
  • DailyMed. Zulresso- brexanolone injection, solution. (2019).
  • ScottLJ. “Brexanolone: first global approval“. Drugs79(7), 779–783 (2019).
  • Press release. “FDA approves first treatment for postpartum depression”. US FDA (2019).
  • KokateTG , SvenssonBE , RogawskiMA. “Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation“. J. Pharmacol. Exp. Ther.270(3), 1223–1229 (1994).
  • CarterRB , WoodPL , WielandSet al.“Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alphahydroxy-3beta-methyl-5alphapregnan-20-one), a selective, high affinity, steroid modulator of the references gamma-aminobutyric acid-A receptor“. J. Pharmacol. Exp. Ther.280(3), 1284–1295 (1997).
  • MonaghanEP , NavaltaLA , ShumL , AshbrookDW , LeeDA. “Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity“. Epilepsia38(9), 1026–1031 (1997).
  • PieriboneVA , TsaiJ , SouffletCet al.“Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy“. Epilepsia48(10), 1870–1874 (2007).
  • LuscherB , ShenQ , SahirN. The GABAergic deficit hypothesis of major depressive disorder. Mol. Psychiatry16(4), 383–406 (2011).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.